CHE  Chemed Corp.




Health Care


Medical/Nursing Services

Market Cap.


Vuru Grade


Current Price

+0.39 (+0.29%)

Growth Price

Overvalued by 55.85%

Stability Price

Overvalued by 25.52%

Company Metrics

  • 22.66 P/E
  • 1.53 P/S
  • 4.75 P/B
  • 5.86 EPS
  • 17.14% Cash ROIC
  • 0.08 Cash Ratio
  • 0.88 / 0.7% Dividend
  • 128,758.00 Avg. Vol.
  • 2.27B Market Cap.

Company Description

Chemed Corporation, through its subsidiaries, provides hospice care, and repair and cleaning services in the United States. The company operates in two segments, Vitas and Roto-Rooter. The Vitas segment offers hospice services to terminally ill patients. This segment provides hospice services in the areas of routine home care, general inpatient care, continuous care, and Medicare cap. It also offe...

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares ...
Yahoo Finance UK - May 18, 2015
Shareholders of Chemed Corporation (CHE) today elected a slate of 10 directors at the Company's 2015 annual shareholders' meeting.
Inside Sale: Arthur Tucker Unloaded 9000 Shares of Chemed Corporation ... -
Company Price Target Watch: Chemed Corp. (NYSE:CHE) - Markets Daily
Chemed Corporation (NYSE:CHE)'s Stock Insider Trade - Kevin Mcnamara Sells ... - May 8, 2015
Based on an average price per share of $120.8, Kevin Mcnamara, the Chemed Corporation (NYSE:CHE) 132.80 +0.39 0.29% 's president and CEO made a sale of 8,000 shares of Chemed Corp worth roughly $966,560 U.S Dollars. Currently, Mr. Kevin, has ...
Chemed Corporation to Present at the Jefferies 2015 Global Healthcare ...
MarketWatch - May 5, 2015
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation ( operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.
A Value Investor's Dream: Chemed Corporation
Seeking Alpha - Nov 5, 2013
Chemed Corporation (NYSE:CHE) is the parent company of two subsidies: 1) Roto-Rooter and 2) VITAS. Roto-Rooter operates through 110 company-owned branches and independent contractors, and over 400 franchisees.
Insider Trade: Donald Saunders Sold 400 Shares of Chemed Corporation ... - May 15, 2015
The director of Chemed Corporation (NYSE:CHE) 132.41 +2.06 1.58% , Donald Saunders is in the stock market news today. It was made public in a legal form filled by Donald Saunders and submitted to the (SEC) on May 15, 2015, he unloaded 400 shares ...
Chemed Corporation to Present at the Bank of America Merrill Lynch 2015 ...
MarketWatch - May 4, 2012
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation ( operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.
Chemed Corporation (CHE) CEO Kevin McNamara on Q4 2014 Results ...
Seeking Alpha (registration) - Feb 18, 2015
Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2014 Chemed Corporation Earnings Conference Call. My name is Derrick, and I'll be your operator for today.
Chemed Reports Fourth-Quarter 2014 Results - Business Wire (press release)
Stock Rating Update on Chemed Corp. (NYSE:CHE)
Investor Newswire - Jun 10, 2015
Chemed Corp. (NYSE:CHE) has been issued a 2.33 rating by the sell-side brokerage firms covering the stock. Basing the rating on a simplified scale where 1 represents a Buy and 5 represents a Sell, this is the average rating based on the 2 firms polled ...
Analysts Anticipate Chemed to Announce $1.52 EPS (NYSE:CHE) - The Legacy
Lawsuit on Behalf of Investors in Chemed Corporation (CHE) Announced by ...
GlobeNewswire (press release) - Sep 17, 2013
SAN DIEGO, Sept. 17, 2013 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending on behalf of certain purchasers of Chemed Corporation (CHE) common stock over alleged violations of Federal Securities Laws by ...
Chemed Corporation (CHE): Hedge Funds Are Bullish and Insiders Are ... - Insider Monkey (blog)
Chemed Looks Good After Another Earnings Beat (CHE)
Seeking Alpha - May 11, 2015
Chemed's management guides for revenue growth of three to four percent from Vitas as well as from Roto-Rooter. The company's management does also forecast further margin expansion in its Vitas segment (EBITDA margin is expected to come in at 14.5% ...